bioMérieux S.A. (EPA:BIM)
France · Delayed Price · Currency is EUR 78.75
-0.95 (-1.19%)
Sep 29, 2026, 5:35 PM CET
bioMérieux Market Cap
bioMérieux has a market cap or net worth of €9.38 billion as of September 29, 2026. Its market cap has decreased by -29.69% in one year.
Market Cap
9.38B
Enterprise Value
9.15B
Revenue
3.99B
Ranking
n/a
PE Ratio
20.43
Stock Price
€78.75
ChartMarket Cap Chart
Since July 7, 2004, bioMérieux's market cap has increased from 1.18B to 9.38B, an increase of 692.49%. That is a compound annual growth rate of 9.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 9.38B | -27.97% |
| Dec 31, 2025 | 13.02B | 6.63% |
| Dec 31, 2024 | 12.21B | 2.78% |
| Dec 29, 2023 | 11.88B | 2.52% |
| Dec 30, 2022 | 11.59B | -21.58% |
| Dec 31, 2021 | 14.78B | 8.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 86.01B |
| EssilorLuxottica Société anonyme | 66.14B |
| Sartorius Stedim Biotech | 20.67B |
| Eurofins Scientific SE | 13.43B |
| Ipsen | 11.75B |
| ABIVAX Société Anonyme | 7.14B |
| Virbac | 2.54B |
| emeis Société anonyme | 1.81B |